This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:pathogenesis:microbiota:interaction [03.12.2020] – [Effects of bacteria on their human host] sallieq | home:pathogenesis:microbiota:interaction [03.31.2020] – [Viruses] sallieq | ||
---|---|---|---|
Line 28: | Line 28: | ||
Several teams researching coronavirus [[https:// | Several teams researching coronavirus [[https:// | ||
+ | |||
+ | [[https:// | ||
+ | |||
+ | [[https:// | ||
+ | |||
+ | [[https:// | ||
+ | |||
+ | [[http:// | ||
+ | |||
+ | [[http:// | ||
+ | |||
+ | current evidence(({{pubmed> | ||
+ | |||
+ | breakthrough(({{pubmed> | ||
+ | |||
+ | chloroquine (({{pubmed> | ||
+ | |||
+ | | ||
+ | |||
+ | Unique epidemiological and clinical features(({{pubmed> | ||
+ | |||
+ | What we know so far(({{pubmed> | ||
+ | |||
+ | Presumed Asymptomatic Carrier Transmission(({{pubmed> | ||
+ | |||
+ | Discovering drugs(({{pubmed> | ||
+ | |||
+ | |||
+ | [[https:// | ||
+ | |||
+ | February 2020 The multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia developed this expert consensus after extensive discussion. It recommended chloroquine phosphate tablet, 500mg twice per day for 10 days for patients diagnosed as mild, moderate and severe cases of novel coronavirus pneumonia and without contraindications to chloroquine. (({{pubmed> | ||
+ | |||
+ | Drug used for Ebola is being tested on 600 participants in a study started March 15, 2020 and expected to complete in May 2020 [[https:// | ||
+ | |||
+ | |||
==== Bacteria ==== | ==== Bacteria ==== |